| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 4.11e-06 | 8 | 85 | 3 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 4.11e-06 | 8 | 85 | 3 | GO:0004972 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 4.85e-05 | 17 | 85 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 8.05e-05 | 20 | 85 | 3 | GO:0016894 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.02e-04 | 57 | 85 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.24e-04 | 60 | 85 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.70e-04 | 65 | 85 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.70e-04 | 65 | 85 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.02e-04 | 27 | 85 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.95e-04 | 75 | 85 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.07e-04 | 31 | 85 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 3.27e-04 | 77 | 85 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 3.71e-04 | 7 | 85 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 8.79e-04 | 100 | 85 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | DNA endonuclease activity, producing 3'-phosphomonoesters | 9.61e-04 | 11 | 85 | 2 | GO:0016889 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.00e-03 | 599 | 85 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.41e-03 | 193 | 85 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.54e-03 | 197 | 85 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | glutamate binding | 1.58e-03 | 14 | 85 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.84e-03 | 654 | 85 | 9 | GO:0008233 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | LPIN1 RIDA RNASEL PTPRB PTPRG PFKFB3 EME2 IDS PLA2G15 DNASE2 | 2.22e-03 | 807 | 85 | 10 | GO:0016788 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 2.34e-03 | 17 | 85 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 2.34e-03 | 17 | 85 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | NADP binding | 2.35e-03 | 62 | 85 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.62e-03 | 18 | 85 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.72e-03 | 136 | 85 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | amino acid binding | 3.74e-03 | 73 | 85 | 3 | GO:0016597 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 3.07e-05 | 43 | 86 | 4 | GO:2000463 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 3.07e-05 | 43 | 86 | 4 | GO:0051968 | |
| GeneOntologyBiologicalProcess | excitatory chemical synaptic transmission | 3.77e-05 | 16 | 86 | 3 | GO:0098976 | |
| GeneOntologyBiologicalProcess | directional locomotion | 1.03e-04 | 4 | 86 | 2 | GO:0033058 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRE RELN BCO2 DSG2 FOXP1 GRIN2A GRIN2B GRIN2C SLC4A4 PPP2R3C | 1.10e-04 | 559 | 86 | 10 | GO:0042391 |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 1.42e-04 | 272 | 86 | 7 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 1.42e-04 | 272 | 86 | 7 | GO:0046395 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 1.57e-04 | 65 | 86 | 4 | GO:0098815 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.90e-04 | 27 | 86 | 3 | GO:0035235 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 5.35e-06 | 9 | 85 | 3 | GO:0017146 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 3.34e-05 | 45 | 85 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 5.08e-05 | 50 | 85 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 4.53e-04 | 157 | 85 | 5 | GO:0098839 | |
| MousePheno | abnormal NMDA-mediated synaptic currents | 4.41e-06 | 22 | 72 | 4 | MP:0002888 | |
| Domain | NMDAR2_C | 8.78e-08 | 3 | 84 | 3 | PF10565 | |
| Domain | NMDAR2_C | 8.78e-08 | 3 | 84 | 3 | IPR018884 | |
| Domain | Iontro_rcpt | 6.82e-05 | 18 | 84 | 3 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 6.82e-05 | 18 | 84 | 3 | PF10613 | |
| Domain | Iono_rcpt_met | 6.82e-05 | 18 | 84 | 3 | IPR001508 | |
| Domain | Glu/Gly-bd | 6.82e-05 | 18 | 84 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.82e-05 | 18 | 84 | 3 | SM00918 | |
| Domain | Lig_chan | 6.82e-05 | 18 | 84 | 3 | PF00060 | |
| Domain | PBPe | 6.82e-05 | 18 | 84 | 3 | SM00079 | |
| Domain | Desmosomal_cadherin | 4.14e-04 | 7 | 84 | 2 | IPR009122 | |
| Domain | ANF_lig-bd_rcpt | 6.11e-04 | 37 | 84 | 3 | IPR001828 | |
| Domain | ANF_receptor | 6.11e-04 | 37 | 84 | 3 | PF01094 | |
| Domain | Peripla_BP_I | 7.14e-04 | 39 | 84 | 3 | IPR028082 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.76e-03 | 14 | 84 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.76e-03 | 14 | 84 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.76e-03 | 14 | 84 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.76e-03 | 14 | 84 | 2 | PF08393 | |
| Domain | MT | 1.76e-03 | 14 | 84 | 2 | PF12777 | |
| Domain | AAA_8 | 1.76e-03 | 14 | 84 | 2 | PF12780 | |
| Domain | DHC_fam | 2.02e-03 | 15 | 84 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.02e-03 | 15 | 84 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.02e-03 | 15 | 84 | 2 | PF03028 | |
| Domain | EGF_extracell | 2.50e-03 | 60 | 84 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.50e-03 | 60 | 84 | 3 | PF07974 | |
| Domain | Fd_Rdtase_FAD-bd | 3.25e-03 | 19 | 84 | 2 | IPR017927 | |
| Domain | FAD_FR | 3.25e-03 | 19 | 84 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 3.25e-03 | 19 | 84 | 2 | IPR017938 | |
| Domain | HEAT_REPEAT | 3.87e-03 | 70 | 84 | 3 | PS50077 | |
| Domain | EGF-like_dom | 5.31e-03 | 249 | 84 | 5 | IPR000742 | |
| Domain | Cadherin_cytoplasmic-dom | 5.61e-03 | 25 | 84 | 2 | IPR000233 | |
| Domain | Cadherin_C | 5.61e-03 | 25 | 84 | 2 | PF01049 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 1.02e-06 | 5 | 67 | 3 | M47667 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 2.03e-06 | 6 | 67 | 3 | M47668 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 4.48e-05 | 15 | 67 | 3 | M47691 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 7.13e-05 | 47 | 67 | 4 | M39531 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 7.96e-05 | 18 | 67 | 3 | M48098 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 7.96e-05 | 18 | 67 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 9.42e-05 | 19 | 67 | 3 | M47677 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.10e-04 | 20 | 67 | 3 | MM1445 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.28e-04 | 21 | 67 | 3 | M27736 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.28e-04 | 21 | 67 | 3 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.28e-04 | 21 | 67 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.28e-04 | 21 | 67 | 3 | M27944 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 1.70e-04 | 23 | 67 | 3 | M27949 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.20e-04 | 5 | 67 | 2 | MM15655 | |
| Pathway | PID_REELIN_PATHWAY | 3.09e-04 | 28 | 67 | 3 | M69 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 4.18e-04 | 74 | 67 | 4 | MM15962 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION | 4.60e-04 | 7 | 67 | 2 | M47869 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 5.06e-04 | 33 | 67 | 3 | M39875 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 6.55e-04 | 36 | 67 | 3 | M39831 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 9.77e-04 | 10 | 67 | 2 | M27178 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 9.77e-04 | 10 | 67 | 2 | MM14892 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.18e-03 | 44 | 67 | 3 | M27934 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 1.19e-03 | 11 | 67 | 2 | M27177 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 1.19e-03 | 11 | 67 | 2 | MM14891 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 1.42e-03 | 12 | 67 | 2 | M47953 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.48e-03 | 261 | 67 | 6 | M42565 | |
| Pathway | WP_RETT_SYNDROME | 1.52e-03 | 48 | 67 | 3 | M39759 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.68e-03 | 13 | 67 | 2 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 1.68e-03 | 13 | 67 | 2 | M27661 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 1.71e-03 | 50 | 67 | 3 | M39822 | |
| Pubmed | 1.74e-10 | 5 | 86 | 4 | 9004271 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 15519237 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 18685090 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 1377365 | ||
| Pubmed | Heteromeric NMDA receptors: molecular and functional distinction of subtypes. | 5.83e-08 | 4 | 86 | 3 | 1350383 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 8595214 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 8699248 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 8965641 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 8601798 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 9768843 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 9147327 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 21945132 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 11488959 | ||
| Pubmed | Differential distributions of the NMDA receptor channel subunit mRNAs in the mouse retina. | 1.45e-07 | 5 | 86 | 3 | 7510577 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 7929904 | ||
| Pubmed | Reelin signaling facilitates maturation of CA1 glutamatergic synapses. | 1.45e-07 | 5 | 86 | 3 | 17229826 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 26919761 | ||
| Pubmed | Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem. | 1.45e-07 | 5 | 86 | 3 | 7518475 | |
| Pubmed | Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum. | 1.45e-07 | 5 | 86 | 3 | 7518474 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 8015722 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 15003177 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 7723623 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 12082569 | ||
| Pubmed | Developmental changes in distribution of NMDA receptor channel subunit mRNAs. | 1.45e-07 | 5 | 86 | 3 | 1493227 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 8036251 | ||
| Pubmed | NMDA receptor activation by HIV-Tat protein is clade dependent. | 1.45e-07 | 5 | 86 | 3 | 19020013 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 26875626 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 8756432 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 18233995 | ||
| Pubmed | 2.90e-07 | 6 | 86 | 3 | 23665428 | ||
| Pubmed | 2.90e-07 | 6 | 86 | 3 | 8996814 | ||
| Pubmed | Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine. | 2.90e-07 | 6 | 86 | 3 | 25760043 | |
| Pubmed | Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. | 2.90e-07 | 6 | 86 | 3 | 9458051 | |
| Pubmed | 2.90e-07 | 6 | 86 | 3 | 15317856 | ||
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 12103442 | ||
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 23267846 | ||
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 19036954 | ||
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 21664258 | ||
| Pubmed | NMDA-receptor proteins are upregulated in the hippocampus of postnatal heterozygous reeler mice. | 5.07e-07 | 7 | 86 | 3 | 16438943 | |
| Pubmed | HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors. | 5.07e-07 | 7 | 86 | 3 | 22940423 | |
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 22833210 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 8563977 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 7695237 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 17360663 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 8724036 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 8822372 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 21106831 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 10448428 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 8955056 | ||
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 10555109 | ||
| Pubmed | Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. | 8.10e-07 | 8 | 86 | 3 | 8804048 | |
| Pubmed | 8.10e-07 | 8 | 86 | 3 | 8845955 | ||
| Pubmed | HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. | 8.10e-07 | 8 | 86 | 3 | 8821747 | |
| Pubmed | 1.21e-06 | 9 | 86 | 3 | 21670103 | ||
| Pubmed | 1.21e-06 | 9 | 86 | 3 | 17526495 | ||
| Pubmed | 1.21e-06 | 9 | 86 | 3 | 21491143 | ||
| Pubmed | D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity. | 1.21e-06 | 9 | 86 | 3 | 22552781 | |
| Pubmed | 1.21e-06 | 9 | 86 | 3 | 9892651 | ||
| Pubmed | 1.21e-06 | 9 | 86 | 3 | 16554481 | ||
| Pubmed | 1.73e-06 | 10 | 86 | 3 | 19332541 | ||
| Pubmed | HIV-1 Tat-mediated apoptosis in human blood-retinal barrier-associated cells. | 2.37e-06 | 11 | 86 | 3 | 24739951 | |
| Pubmed | 2.37e-06 | 11 | 86 | 3 | 8581564 | ||
| Pubmed | 2.37e-06 | 11 | 86 | 3 | 9647694 | ||
| Pubmed | Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. | 2.37e-06 | 11 | 86 | 3 | 16481105 | |
| Pubmed | 3.16e-06 | 12 | 86 | 3 | 8665664 | ||
| Pubmed | 3.16e-06 | 12 | 86 | 3 | 12815021 | ||
| Pubmed | 3.16e-06 | 12 | 86 | 3 | 11937501 | ||
| Pubmed | Crybb2 coding for βB2-crystallin affects sensorimotor gating and hippocampal function. | 4.10e-06 | 13 | 86 | 3 | 24096375 | |
| Pubmed | 5.21e-06 | 14 | 86 | 3 | 15749123 | ||
| Pubmed | Attenuation of focal cerebral infarct in mice lacking NMDA receptor subunit NR2C. | 6.04e-06 | 2 | 86 | 2 | 9512392 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 25131300 | ||
| Pubmed | NMDA receptor NR2B subunit over-expression increases cerebellar granule cell migratory activity. | 6.04e-06 | 2 | 86 | 2 | 18005003 | |
| Pubmed | Conditioned eyeblink response is impaired in mutant mice lacking NMDA receptor subunit NR2A. | 6.04e-06 | 2 | 86 | 2 | 9427357 | |
| Pubmed | Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. | 6.04e-06 | 2 | 86 | 2 | 20921396 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 27199241 | ||
| Pubmed | The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. | 6.04e-06 | 2 | 86 | 2 | 16901514 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 10972963 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20696923 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23618906 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 19474217 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 31757807 | ||
| Pubmed | Importance of the GluN2B carboxy-terminal domain for enhancement of social memories. | 6.04e-06 | 2 | 86 | 2 | 26179233 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22329647 | ||
| Pubmed | Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. | 6.04e-06 | 2 | 86 | 2 | 16033900 | |
| Pubmed | iNOS- and NOX1-dependent ROS production maintains bacterial homeostasis in the ileum of mice. | 6.04e-06 | 2 | 86 | 2 | 29210363 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21919190 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 38214768 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 21503117 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18372311 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 32247039 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 34070827 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 12427824 | ||
| Pubmed | Separate functional properties of NMDARs regulate distinct aspects of spatial cognition. | 6.04e-06 | 2 | 86 | 2 | 29764972 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 27605622 | ||
| Pubmed | Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function. | 6.04e-06 | 2 | 86 | 2 | 33043365 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 30355491 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 12127670 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20890276 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16045501 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 27915379 | ||
| Cytoband | 5q11.2 | 1.31e-04 | 52 | 86 | 3 | 5q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q11 | 7.76e-04 | 95 | 86 | 3 | chr5q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q12 | 1.01e-03 | 104 | 86 | 3 | chr18q12 | |
| Cytoband | 18q12.1 | 1.09e-03 | 26 | 86 | 2 | 18q12.1 | |
| Cytoband | 17q25 | 2.46e-03 | 39 | 86 | 2 | 17q25 | |
| Cytoband | 4p14 | 2.84e-03 | 42 | 86 | 2 | 4p14 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 8.26e-07 | 7 | 53 | 3 | 1201 | |
| GeneFamily | Desmosomal cadherins | 1.75e-04 | 7 | 53 | 2 | 1188 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.71e-03 | 21 | 53 | 2 | 813 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | MAPK8IP1 LPIN1 SMG1 HIVEP2 PTPRB COPA TCN1 USP32 OLFM1 IDS PRDM1 | 6.67e-07 | 495 | 86 | 11 | M8451 |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-06 | 188 | 86 | 6 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-06 | 188 | 86 | 6 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 195 | 86 | 6 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | Caecum-(2)_B_cell-(21)_B_cell_IgG_Plasma|Caecum / shred on region, Cell_type, and subtype | 2.36e-06 | 198 | 86 | 6 | 3893fcfc1de5937be3ccc7e545f711f2c95a2827 | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.36e-06 | 198 | 86 | 6 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | Caecum-B_cell-B_cell_IgG_Plasma|Caecum / Region, Cell class and subclass | 2.36e-06 | 198 | 86 | 6 | d8cb78b1763710a158cf22b59aebaa44afd2374c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-05 | 166 | 86 | 5 | 4d63c758d46e73311b864148c646bf081498dee7 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-05 | 166 | 86 | 5 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-05 | 166 | 86 | 5 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-05 | 166 | 86 | 5 | 4160ccf9291072a6e2782f9ad141bc9a9747f3ad | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 167 | 86 | 5 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 167 | 86 | 5 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|normal_Lung / Location, Cell class and cell subclass | 2.33e-05 | 176 | 86 | 5 | f31d7234053085a82cf9d55aeedd1e04d34789c3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 177 | 86 | 5 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 177 | 86 | 5 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.40e-05 | 177 | 86 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 178 | 86 | 5 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 178 | 86 | 5 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 181 | 86 | 5 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 184 | 86 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 184 | 86 | 5 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 184 | 86 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 184 | 86 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.89e-05 | 184 | 86 | 5 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 184 | 86 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.04e-05 | 186 | 86 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.12e-05 | 187 | 86 | 5 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-05 | 187 | 86 | 5 | e61992de4f98eeea08b43213850769d923f8db48 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 3.12e-05 | 187 | 86 | 5 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 3.20e-05 | 188 | 86 | 5 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.20e-05 | 188 | 86 | 5 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.20e-05 | 188 | 86 | 5 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Hpcal1-Fos_(Entorhinal_cortex_(IEG))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.33e-05 | 94 | 86 | 4 | a4d0eefede392b55d17ae9995237a2278a570e42 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Hpcal1-Fos_(Entorhinal_cortex_(IEG))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.33e-05 | 94 | 86 | 4 | 517e9762e5362b6ff48f0918468a70b736f4d0de | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.36e-05 | 190 | 86 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-05 | 190 | 86 | 5 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-05 | 190 | 86 | 5 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.36e-05 | 190 | 86 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 3.36e-05 | 190 | 86 | 5 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.45e-05 | 191 | 86 | 5 | 7b4b5d90d1023d03239ed986f273afa734d3124d | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.45e-05 | 191 | 86 | 5 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 191 | 86 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 3.54e-05 | 192 | 86 | 5 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.54e-05 | 192 | 86 | 5 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 3.54e-05 | 192 | 86 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 193 | 86 | 5 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 193 | 86 | 5 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 193 | 86 | 5 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 193 | 86 | 5 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 193 | 86 | 5 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 193 | 86 | 5 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 193 | 86 | 5 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 193 | 86 | 5 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.62e-05 | 193 | 86 | 5 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-05 | 194 | 86 | 5 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.71e-05 | 194 | 86 | 5 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | severe-Plasmablast|World / disease stage, cell group and cell class | 3.71e-05 | 194 | 86 | 5 | 49e8f90db571a89b8a26aef31fcacd66429fed11 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.71e-05 | 194 | 86 | 5 | ffba703f61faaac8b4b9a5e46cd335214303de7b | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.71e-05 | 194 | 86 | 5 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.71e-05 | 194 | 86 | 5 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.71e-05 | 194 | 86 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-05 | 194 | 86 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.71e-05 | 194 | 86 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.71e-05 | 194 | 86 | 5 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-05 | 194 | 86 | 5 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-05 | 194 | 86 | 5 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.81e-05 | 195 | 86 | 5 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 195 | 86 | 5 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 195 | 86 | 5 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 195 | 86 | 5 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 195 | 86 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 195 | 86 | 5 | db4270c135c392ed443670981656e3cd5b95939d | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.81e-05 | 195 | 86 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 195 | 86 | 5 | 6365e3893e38231090ec2dbef010dec71dea3d07 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-05 | 195 | 86 | 5 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.81e-05 | 195 | 86 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.81e-05 | 195 | 86 | 5 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 195 | 86 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.90e-05 | 196 | 86 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.90e-05 | 196 | 86 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.00e-05 | 197 | 86 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.00e-05 | 197 | 86 | 5 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | ILEUM-inflamed-(5)_Plasmablasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.00e-05 | 197 | 86 | 5 | 8710a586fc91cf664032a12e4d2a0399b370cbcb | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.00e-05 | 197 | 86 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.00e-05 | 197 | 86 | 5 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.00e-05 | 197 | 86 | 5 | 6fe013f98c64b3c5a4e61002254717fb411f8e59 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.00e-05 | 197 | 86 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | B_cells-Plasmablasts|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.09e-05 | 198 | 86 | 5 | c6cab47885be74a64351f843a741dea6d911bde4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.09e-05 | 198 | 86 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.09e-05 | 198 | 86 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.09e-05 | 198 | 86 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.19e-05 | 199 | 86 | 5 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 199 | 86 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.19e-05 | 199 | 86 | 5 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Transverse-(2)_B_cell-(20)_B_cell_IgA_Plasma|Transverse / shred on region, Cell_type, and subtype | 4.19e-05 | 199 | 86 | 5 | 8caaa08b046f766af298d03961ccac6e4569e2a6 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.19e-05 | 199 | 86 | 5 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | Transverse-B_cell-B_cell_IgA_Plasma|Transverse / Region, Cell class and subclass | 4.19e-05 | 199 | 86 | 5 | ea65cadaf464ff4c1040fceb5f3724706f8447c1 | |
| Drug | conotoxin GV | 5.02e-08 | 3 | 85 | 3 | ctd:C055407 | |
| Drug | Agmatine | 1.26e-07 | 13 | 85 | 4 | ctd:D000376 | |
| Drug | DPCPX | 2.80e-07 | 117 | 85 | 7 | CID000001329 | |
| Drug | NSC221991 | 2.90e-07 | 72 | 85 | 6 | CID000004580 | |
| Drug | metaphit | 3.18e-07 | 16 | 85 | 4 | CID000114745 | |
| Drug | 5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione | 4.99e-07 | 5 | 85 | 3 | ctd:C498554 | |
| Drug | 2-Aminoadipic Acid | 4.99e-07 | 5 | 85 | 3 | ctd:D015074 | |
| Drug | (2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid | 4.99e-07 | 5 | 85 | 3 | ctd:C491996 | |
| Drug | SDZ EAA 494 | 4.99e-07 | 5 | 85 | 3 | ctd:C065286 | |
| Drug | QX-314 | 6.32e-07 | 82 | 85 | 6 | CID000003925 | |
| Drug | C22H28N2O4 | 6.72e-07 | 19 | 85 | 4 | CID000065570 | |
| Drug | Meperidine | 9.96e-07 | 6 | 85 | 3 | DB00454 | |
| Drug | 1,5-(diethylamino)piperidine | 9.96e-07 | 6 | 85 | 3 | CID000004025 | |
| Drug | Naphthols | 9.96e-07 | 6 | 85 | 3 | ctd:D009284 | |
| Drug | N(G)-nitro-L-arginine methyl ester | 1.25e-06 | 146 | 85 | 7 | CID000003864 | |
| Drug | Tenocyclidine | 1.74e-06 | 7 | 85 | 3 | DB01520 | |
| Drug | tetrazol-5-yl)glycine | 1.74e-06 | 7 | 85 | 3 | CID000126383 | |
| Drug | 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid | 1.74e-06 | 7 | 85 | 3 | ctd:C050592 | |
| Drug | homoquinolinate | 1.74e-06 | 7 | 85 | 3 | CID003080554 | |
| Drug | S)-piperazine-2-carboxylic acid | 1.74e-06 | 7 | 85 | 3 | CID001502069 | |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 1.82e-06 | 24 | 85 | 4 | CID003645780 | |
| Drug | CP-96,345 | 1.93e-06 | 55 | 85 | 5 | CID000104943 | |
| Drug | perzinfotel | 2.77e-06 | 8 | 85 | 3 | CID006918236 | |
| Drug | L-687,414 | 2.77e-06 | 8 | 85 | 3 | CID000125556 | |
| Drug | 6-chloroquinoxaline-2,3-diol | 2.77e-06 | 8 | 85 | 3 | CID000081143 | |
| Drug | ES-242-1 | 2.77e-06 | 8 | 85 | 3 | CID000131976 | |
| Drug | SDZ 220-581 | 2.77e-06 | 8 | 85 | 3 | CID000128019 | |
| Drug | 3alpha5betaHS | 2.77e-06 | 8 | 85 | 3 | CID000165024 | |
| Drug | neramexane | 2.77e-06 | 8 | 85 | 3 | CID006433106 | |
| Drug | piperazine-2,3-dicarboxylic acid | 2.77e-06 | 8 | 85 | 3 | CID000280973 | |
| Drug | Phenanthrenes | 4.15e-06 | 9 | 85 | 3 | ctd:D010616 | |
| Drug | sodium alpha-oxyhyponitrite | 4.60e-06 | 30 | 85 | 4 | CID010129945 | |
| Drug | picrotoxin | 5.23e-06 | 181 | 85 | 7 | CID000031304 | |
| Drug | DCG-IV | 5.58e-06 | 68 | 85 | 5 | CID000115114 | |
| Drug | nylidrin | 5.91e-06 | 10 | 85 | 3 | CID000004567 | |
| Drug | AC1L1ICP | 5.91e-06 | 10 | 85 | 3 | CID000004520 | |
| Drug | EAB 515 | 8.11e-06 | 11 | 85 | 3 | CID000159489 | |
| Drug | 5-phosphonopentanoic acid | 8.11e-06 | 11 | 85 | 3 | CID002773807 | |
| Drug | oxiracetam | 8.11e-06 | 11 | 85 | 3 | CID000004626 | |
| Drug | o-difluorobenzene | 8.11e-06 | 11 | 85 | 3 | CID000009706 | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 9.11e-06 | 197 | 85 | 7 | 7447_UP | |
| Drug | pentylenetetrazol | 9.33e-06 | 130 | 85 | 6 | CID000005917 | |
| Drug | 3-bromo-7-nitroindazole | 9.73e-06 | 36 | 85 | 4 | CID000001649 | |
| Drug | glutamic acid diethyl ester | 9.73e-06 | 36 | 85 | 4 | CID000073960 | |
| Drug | CI-1041 | 1.08e-05 | 12 | 85 | 3 | CID000156328 | |
| Drug | tenocyclidine | 1.08e-05 | 12 | 85 | 3 | CID000062751 | |
| Drug | GAMs | 1.21e-05 | 38 | 85 | 4 | CID000002935 | |
| Drug | DETC-MeSO | 1.35e-05 | 39 | 85 | 4 | CID003035711 | |
| Drug | GCV-MP | 1.35e-05 | 39 | 85 | 4 | CID000146785 | |
| Drug | NSC-72942 | 1.38e-05 | 2 | 85 | 2 | CID000130797 | |
| Drug | 1,10-diaminodecane | 1.40e-05 | 13 | 85 | 3 | CID000001317 | |
| Drug | butanol | 1.54e-05 | 142 | 85 | 6 | CID000000263 | |
| Drug | L000369 | 1.65e-05 | 41 | 85 | 4 | CID003931705 | |
| Drug | remacemide | 1.77e-05 | 14 | 85 | 3 | CID000060510 | |
| Drug | LY341495 | 2.00e-05 | 43 | 85 | 4 | CID006324636 | |
| Drug | ACEA-1011 | 2.21e-05 | 15 | 85 | 3 | CID000127872 | |
| Drug | thiokynurenic acid | 2.21e-05 | 15 | 85 | 3 | CID003035667 | |
| Drug | aurintricarboxylic acid | 2.33e-05 | 91 | 85 | 5 | CID000002259 | |
| Drug | 7-chlorokynurenic acid | 2.40e-05 | 45 | 85 | 4 | CID000001884 | |
| Drug | oriens | 2.45e-05 | 154 | 85 | 6 | CID000161645 | |
| Drug | argiopine | 2.72e-05 | 16 | 85 | 3 | CID000122294 | |
| Drug | 3,4,7,8-tetrahydroquinoline | 2.72e-05 | 16 | 85 | 3 | CID000094356 | |
| Drug | LY233536 | 2.72e-05 | 16 | 85 | 3 | CID000126239 | |
| Drug | NaCN | 2.85e-05 | 47 | 85 | 4 | CID000008929 | |
| Drug | PRE-084 | 3.29e-05 | 17 | 85 | 3 | CID000126402 | |
| Drug | 7-Cl-Thio-Kyna | 3.29e-05 | 17 | 85 | 3 | CID003035668 | |
| Drug | ADCI | 3.29e-05 | 17 | 85 | 3 | CID000130099 | |
| Drug | AC1L1FA8 | 3.65e-05 | 50 | 85 | 4 | CID000003150 | |
| Drug | phenylpropionic acid | 3.86e-05 | 167 | 85 | 6 | CID000000107 | |
| Drug | 3-hydroxyglutaric acid | 3.93e-05 | 18 | 85 | 3 | CID000181976 | |
| Drug | MNQX | 3.93e-05 | 18 | 85 | 3 | CID000130818 | |
| Drug | AC1O3MDH | 4.04e-05 | 102 | 85 | 5 | CID006332158 | |
| Drug | Felbamate | 4.12e-05 | 3 | 85 | 2 | DB00949 | |
| Drug | SG-86 | 4.12e-05 | 3 | 85 | 2 | CID000072663 | |
| Drug | AC1MPBWG | 4.12e-05 | 3 | 85 | 2 | CID003382771 | |
| Drug | Quinoxaline | 4.27e-05 | 52 | 85 | 4 | CID000007045 | |
| Drug | propanol | 4.61e-05 | 53 | 85 | 4 | CID000001031 | |
| Drug | donepezil | 4.61e-05 | 53 | 85 | 4 | CID000003152 | |
| Drug | arcaine | 4.66e-05 | 19 | 85 | 3 | CID000002227 | |
| Drug | kynurenine | 5.31e-05 | 108 | 85 | 5 | CID000000846 | |
| Drug | IDRA 21 | 5.47e-05 | 20 | 85 | 3 | CID000003688 | |
| Drug | ginsenoside Rc | 5.47e-05 | 20 | 85 | 3 | CID000100018 | |
| Drug | norethisterone oenanthate | 5.55e-05 | 109 | 85 | 5 | CID000019688 | |
| Drug | orphenadrine | 5.73e-05 | 56 | 85 | 4 | CID000004601 | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 5.86e-05 | 180 | 85 | 6 | 5584_UP | |
| Drug | NSC624746 | 6.15e-05 | 57 | 85 | 4 | CID000107640 | |
| Drug | carbetapentane | 6.36e-05 | 21 | 85 | 3 | CID000002562 | |
| Drug | dinor | 6.36e-05 | 21 | 85 | 3 | CID000132460 | |
| Drug | Sulfur Dioxide | 6.58e-05 | 58 | 85 | 4 | ctd:D013458 | |
| Drug | hydroxybutyrate | 7.16e-05 | 115 | 85 | 5 | CID000010413 | |
| Drug | NS 102 | 7.35e-05 | 22 | 85 | 3 | CID005282252 | |
| Drug | CX516 | 7.35e-05 | 22 | 85 | 3 | CID000148184 | |
| Drug | methadone | 7.52e-05 | 60 | 85 | 4 | CID000004095 | |
| Drug | 8-OH-DPAT | 7.77e-05 | 117 | 85 | 5 | CID000001220 | |
| Drug | propofol | 8.13e-05 | 191 | 85 | 6 | CID000004943 | |
| Drug | Poly C | 8.22e-05 | 4 | 85 | 2 | ctd:D011066 | |
| Drug | n-propylbenzene | 8.22e-05 | 4 | 85 | 2 | ctd:C024268 | |
| Drug | isoflurane | 8.41e-05 | 279 | 85 | 7 | CID000003763 | |
| Drug | potassium cyanide | 8.42e-05 | 119 | 85 | 5 | CID000009032 | |
| Drug | AC1L1ICD | 8.43e-05 | 23 | 85 | 3 | CID000004516 | |
| Disease | pulmonary edema (biomarker_via_orthology) | 4.45e-05 | 4 | 81 | 2 | DOID:11396 (biomarker_via_orthology) | |
| Disease | schizophrenia (is_implicated_in) | 6.44e-05 | 78 | 81 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | X-21471 measurement | 1.11e-04 | 6 | 81 | 2 | EFO_0800818 | |
| Disease | glycocholenate sulfate measurement | 1.11e-04 | 6 | 81 | 2 | EFO_0800276 | |
| Disease | Autoinflammatory disorder | 1.22e-04 | 35 | 81 | 3 | C3860213 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 2.06e-04 | 8 | 81 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 2.06e-04 | 8 | 81 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | X-21467 measurement | 2.65e-04 | 9 | 81 | 2 | EFO_0020007 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.35e-04 | 49 | 81 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 4.03e-04 | 11 | 81 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | vascular dementia (is_marker_for) | 4.03e-04 | 11 | 81 | 2 | DOID:8725 (is_marker_for) | |
| Disease | factor VII activating protease measurement | 4.72e-04 | 55 | 81 | 3 | EFO_0009368 | |
| Disease | response to vaccine, cytokine measurement | 4.74e-04 | 131 | 81 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 5.24e-04 | 57 | 81 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | X-21470 measurement | 6.63e-04 | 14 | 81 | 2 | EFO_0800817 | |
| Disease | Mental Depression | 6.83e-04 | 254 | 81 | 5 | C0011570 | |
| Disease | Autistic Disorder | 7.72e-04 | 261 | 81 | 5 | C0004352 | |
| Disease | epilepsy (implicated_via_orthology) | 1.07e-03 | 163 | 81 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | temporal lobe epilepsy (is_marker_for) | 1.37e-03 | 20 | 81 | 2 | DOID:3328 (is_marker_for) | |
| Disease | HbA1c measurement, response to sulfonylurea | 1.51e-03 | 21 | 81 | 2 | EFO_0004541, EFO_0007922 | |
| Disease | Autism Spectrum Disorders | 1.67e-03 | 85 | 81 | 3 | C1510586 | |
| Disease | Huntington's disease (is_implicated_in) | 1.81e-03 | 23 | 81 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.98e-03 | 24 | 81 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.98e-03 | 24 | 81 | 2 | C3805278 | |
| Disease | refractive error | 2.06e-03 | 326 | 81 | 5 | MONDO_0004892 | |
| Disease | TEMPS-A questionnaire | 2.14e-03 | 25 | 81 | 2 | EFO_0004783 | |
| Disease | Cholangiocarcinoma | 2.32e-03 | 26 | 81 | 2 | C0206698 | |
| Disease | Abnormality of refraction | 2.52e-03 | 673 | 81 | 7 | HP_0000539 | |
| Disease | amino acid measurement | 2.62e-03 | 678 | 81 | 7 | EFO_0005134 | |
| Disease | Barrett's esophagus | 2.69e-03 | 28 | 81 | 2 | EFO_0000280 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGVFTDIEQYQFIYK | 1391 | P23470 | |
| FQEENPGVFYQYVIS | 586 | Q6UY14 | |
| DTGVFRGQVYFKPQY | 51 | Q9UH17 | |
| GKQSFLPQNFLVYTY | 61 | Q9Y3Q7 | |
| FYSQREKPGIFYQQT | 1096 | Q8TCU4 | |
| FYSQREKPGIFYQQT | 1191 | Q8TCU4 | |
| YSFGEKPIVNYKQAF | 1571 | Q8TCU4 | |
| QFQKSYPEVYQERFP | 476 | Q8WUY9 | |
| QVYFAVYTFKARNPN | 1516 | Q6XZF7 | |
| GRYYSKPFVTFHQIN | 346 | Q9BYV7 | |
| RKDYETYQPFQNSTR | 1151 | Q9UQB3 | |
| PTFYLQKGFQTYVLR | 56 | Q709F0 | |
| GLEDTKSPQFNRYFY | 116 | Q9NTI5 | |
| PTINYTLRDYRKFFQ | 286 | Q8NCC3 | |
| GLEDTKSPQFNRYFY | 126 | Q29RF7 | |
| ISTFGYNRNNKKPYV | 11 | Q15434 | |
| RKNTNEFYKTIPRFY | 46 | Q969Q6 | |
| KLPDFESRYVQNGTY | 451 | Q14126 | |
| PQAIEFVNQYYGSFK | 141 | P35228 | |
| RYSSLDPRKVQFYFN | 546 | Q9Y5S8 | |
| PYNIKFYETVGQDFR | 351 | Q9Y278 | |
| FNPYNNRKSEGRIVY | 1306 | P23467 | |
| FYGYDNLQRQPIFTT | 136 | P13378 | |
| FQQFYKQFVEYTCPT | 691 | Q9UQF2 | |
| KRQEPGNYIFVFNYL | 541 | Q8NBH2 | |
| KIQRTYFYSSNNEQP | 3721 | Q5CZC0 | |
| TGQVVYNGSIYFNKF | 301 | Q99784 | |
| REAVKQYSSYNFFRP | 76 | Q16875 | |
| GNETSSDYYNFQKPR | 126 | Q8N292 | |
| QEFYKNAEVRPPFTY | 456 | Q9H334 | |
| GVYIFQPVFEQYAKD | 21 | A0A0B4J2F0 | |
| AAFGNRPADVYSYKQ | 796 | Q14693 | |
| PDTQYYFDVFVVNIN | 306 | Q8TB73 | |
| RFGYVAFQNYVPSSV | 276 | P78334 | |
| AQQYGVRGYPTIKFF | 91 | P07237 | |
| LPDVYGVFQFKVDYN | 381 | P39656 | |
| ARYQFGYPKLFQASR | 101 | Q96RP7 | |
| FYENNYIVPDKQIFR | 796 | P09884 | |
| FPYFLVRFTVIYNEQ | 36 | Q9H8H3 | |
| EIFYDQYSKPGFVNI | 2611 | P78509 | |
| YVFPDGNANTYIKNT | 341 | Q96FL9 | |
| YPFDQNRFVQYKATS | 51 | Q8N7H5 | |
| PRRFFSYGTKILYQN | 21 | Q16698 | |
| GYYFRFLPQKTFQSL | 11 | Q9BRQ4 | |
| FGPVFNYFTYRIQQN | 2761 | Q8NCM8 | |
| QNPDKLRFNFYTSQY | 71 | X6R8D5 | |
| QPYTLVVFFNKRVYN | 381 | Q8WV28 | |
| VKQEFQPSQSYRYGN | 31 | Q5T4I8 | |
| VYNYQLEGIFAQEFP | 181 | O00115 | |
| SYQKNAGFQEYTIPI | 636 | Q14574 | |
| NGQKFVYKFVSYPEI | 76 | P28324 | |
| QFGPYKQLFLQTYAR | 951 | P53621 | |
| KSFFVELQRYNYVTP | 2546 | Q8WXX0 | |
| QRPFVFNYYENVLEK | 36 | A6NC97 | |
| QYPLKQYRESQAFSF | 256 | A4GXA9 | |
| FSTIPQYFKENGYVT | 116 | P22304 | |
| QRQPYFIYFPQIKTE | 136 | Q96FZ2 | |
| NQYYFRNSVVDPFRK | 16 | Q96L03 | |
| FVALTKGQYPVFNQY | 666 | Q96DN5 | |
| QSPEPENRFIQYFYN | 356 | Q68DH5 | |
| VPYENSVRQFLGEYK | 3446 | Q96Q15 | |
| KPYEGESSYIIFQQF | 111 | Q16819 | |
| KFYEKRGNFYQNTVG | 646 | Q05823 | |
| GTVYQKYEPIFFQSI | 156 | Q8NE22 | |
| NFYQLQVRKFPADYI | 1771 | Q7Z333 | |
| YSFENNYPVGKIQDV | 2406 | Q9UKZ4 | |
| YTNDTVPKNANRKYF | 121 | O75626 | |
| FFKRGGSIQQYIYKQ | 1261 | Q92954 | |
| FTYVFKYVEQQYGQP | 356 | Q9Y6L6 | |
| ESSSNIYYPFQKREQ | 1551 | Q6Q759 | |
| QVVSDVFGFPQSYIY | 306 | Q15399 | |
| EYQKYGSVAFPNFEQ | 386 | O00116 | |
| FDPDGRKYYTNNFIT | 541 | Q9UQC9 | |
| TVNEIYKQYFKSNFP | 91 | P52758 | |
| FFFGVPYRTVYVNNN | 56 | O75443 | |
| VFQKYVPSFSGYSQQ | 286 | Q9UK80 | |
| EKSFYQFQHYRAIPG | 586 | P42285 | |
| TPENKNYYFGSQFSV | 171 | P20061 | |
| SRYIGPQNFYQVKDI | 1876 | Q92576 | |
| FYTEKNGQLIYTPFT | 111 | P49810 | |
| YRPFQYFEKNVQGIV | 371 | Q86VZ5 | |
| VTYEIKVRPYFNEFQ | 706 | Q9HCK4 | |
| YPINSNFKVGYNTLF | 611 | Q9Y6R1 | |
| YSPETFRQQFRQFGY | 46 | Q96N95 | |
| FLNYTKPNYVQQATF | 1651 | P31629 | |
| YQYPFTLRVVQKDGN | 1151 | Q8NFA0 | |
| FYFDRNPYFQNKVLI | 296 | Q86VY4 | |
| RPQGKSYLYFTQFKA | 96 | Q969H8 | |
| FEYFSPVGYNRNLAK | 576 | Q12879 | |
| IVTTYFPGYQDFVNK | 171 | Q13224 | |
| YFSPVSYNQNLTRGK | 576 | Q14957 |